AVITA Medical, Inc. (RCEL) CEO Dr. Mike Perry on Q2 2022 Results - Earnings Call Transcript

Aug. 11, 2022 9:03 PM ETAVITA Medical, Inc. (RCEL), AVHHL1 Comment
SA Transcripts profile picture
SA Transcripts

AVITA Medical, Inc. (NASDAQ:RCEL) Q2 2022 Results Conference Call August 11, 2022 5:00 PM ET

Company Participants

Caroline Corner - Managing Director, Investor Relations

Dr. Mike Perry - Chief Executive Officer

Michael Holder - Chief Financial Officer

Conference Call Participants

Josh Jennings - Cowen

Ryan Zimmerman - BTIG


Hello. Thank you for standing by and welcome to the AVITA Medical Inc. Second Quarter 2022 Earnings Conference Call. At this time, all participants are in listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference maybe recorded.

I would now like to hand the conference over to your speaker today, Caroline Corner. Please go ahead.

Caroline Corner

Thank you, operator. Welcome to AVITA Medical's second quarter 2022 earnings call. Joining me on today's call are Dr. Mike Perry, Chief Executive Officer; and Michael Holder, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which AVITA Medical operates, trends, demand, and expectations for its products and technology, its expected financial performance, expenses, and position in the market, and the impact of COVID-19 on its operations and its customer's operations.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance, or achievements to differ materially from any results performance or achievements expressed or implied by the forward-looking statements.

Please review AVITA Medical's most recent filings with the SEC, particularly the risk factors described in AVITA Medical's S3 and 10-K filings, and in AVITA Medical's quarterly report on Form 10-Q for the first quarter ended June

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.